Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
ANTARES PHARMA, INC. (ATRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 7% stake in ANTARES PHARMA, INC |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 4.8% stake in Antares Pharma, Inc. |
| 02/13/2018 |
SC 13G/A
| Broadfin Capital, LLC reports a 2.9% stake in Antares Pharma, Inc. |
| 02/14/2017 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 7.1% stake in Antares Pharma, Inc. |
| 02/13/2017 |
SC 13G/A
| Broadfin Capital, LLC reports a 8.4% stake in Antares Pharma, Inc. |
| 07/08/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2016 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 8.6% stake in Antares Pharma, Inc. |
| 02/16/2016 |
SC 13G/A
| Flynn James E reports a 2.6% stake in Antares Pharma, Inc. |
| 02/11/2016 |
SC 13G/A
| Broadfin Capital, LLC reports a 7.4% stake in Antares Pharma, Inc. |
| 01/25/2016 |
SC 13G/A
| BlackRock Inc. reports a 5.7% stake in ANTARES PHARMA INC. |
| 11/30/2015 |
SC 13G/A
| Flynn James E reports a 8% stake in Antares Pharma, Inc. |
| 05/13/2015 |
SC 13G/A
| Flynn James E reports a 13.9% stake in Antares Pharma, Inc. |
| 02/17/2015 |
SC 13G/A
| Flynn James E reports a 6.2% stake in Antares Pharma, Inc. |
| 02/02/2015 |
SC 13G/A
| BlackRock Inc. reports a 5.8% stake in ANTARES PHARMA INC |
| 02/14/2014 |
SC 13G/A
| Flynn James E reports a 8% stake in Antares Pharma, Inc. |
| 02/13/2014 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 3.6% stake in Antares Pharma, Inc. |
| 02/14/2013 |
SC 13G/A
| Flynn James E reports a 7.9% stake in Antares Pharma, Inc. |
| 02/14/2013 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 6.3% stake in Antares Pharma, Inc. |
| 02/14/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2011 |
SC 13G/A
| ANTARES PHARMA, INC. reports a 7.3% stake in Antares Pharma, Inc. |
| 07/08/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/20/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
|
|